Literature DB >> 69780

Prolonged maintained remissions of adult acute non-lymphocytic leukaemia.

B A Peterson, C D Bloomfield.   

Abstract

Maintenance chemotherapy consisting of weekly oral 6-thioguanine and intramuscular cytosine arabinoside was administered to 24 adult patients with acute non-lymphocytic leukaemia in complete remission. The median duration of complete remission was 16-5 months, with 9 patients (38%) still in their first remission after 18--56 months. 33% of the patients have been in continuous remission for over 2 yr, 21% for over 3 yr, and 12-5% for over 4 yr. Median survival so far is 22-5 months. This maintenance regimen is well tolerated, is easily administered on an outpatient basis, and produces substantial numbers of long-term remissions.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 69780     DOI: 10.1016/s0140-6736(77)90178-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  7 in total

1.  A phase 1 dose-escalation study of ARRY-520, a kinesin spindle protein inhibitor, in patients with advanced myeloid leukemias.

Authors:  Hanna Jean Khoury; Guillermo Garcia-Manero; Gautam Borthakur; Tapan Kadia; Maria Cielo Foudray; Martha Arellano; Amelia Langston; Beverly Bethelmie-Bryan; Selena Rush; Kevin Litwiler; Sharon Karan; Heidi Simmons; Adam I Marcus; Mieke Ptaszynski; Hagop Kantarjian
Journal:  Cancer       Date:  2011-12-02       Impact factor: 6.860

Review 2.  Inching toward cure of acute myeloid leukemia: a summary of the progress made in the last 50 years.

Authors:  Peter H Wiernik
Journal:  Med Oncol       Date:  2014-07-22       Impact factor: 3.064

3.  Bone marrow transplantation in Canada.

Authors:  N A Buskard
Journal:  Can Med Assoc J       Date:  1980-07-05       Impact factor: 8.262

4.  [Changes of therapy results in acute leukemia under different treatment schedules with special reference to gnotobiotic measures].

Authors:  H Link; H M Frauer; K Wilms; H D Waller
Journal:  Klin Wochenschr       Date:  1983-04-01

Review 5.  Optimal therapy for adult patients with acute myeloid leukemia in first complete remission.

Authors:  Peter H Wiernik
Journal:  Curr Treat Options Oncol       Date:  2014-06

6.  Recurrence of acute myelogenous leukemia with the same AML1/ETO breakpoint as at diagnosis after complete remission lasting 15 years: analysis of stored bone marrow smears.

Authors:  Norifumi Tsukamoto; Masamitsu Karasawa; Yoko Tanaka; Akihiko Yokohama; Hideki Uchiumi; Takafumi Matsushima; Hirokazu Murakami; Yoshihisa Nojima
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

7.  Update on optimal management of acute myeloid leukemia.

Authors:  Fuad El Rassi; Martha Arellano
Journal:  Clin Med Insights Oncol       Date:  2013-08-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.